Friday, 2 March 2012

Food And Drug Administration-Treatment Of Breast Cancer-Healthday News

Steroids May Boost Survival for Very Preemie Babies

TUESDAY, Dec. 6 (Healthday News) -- Giving steroids to pregnant women at risk for preterm birth as early as 23 weeks during their pregnancy may boost an infant's overall chance of survival and reduce the baby's risk of serious developmental issues, including brain injury, a new study says. read more..


Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study

WEDNESDAY, Dec. 7 (Healthday News) -- In November, the U.S. Food And Drug Administration revoked its approval of the drug Avastin for the treatment of Breast Cancer. But, a new study suggests that the drug can boost the survival of women with a specific type of aggressive breast tumor when used in conjunction with two other medications. read more..

No comments:

Post a Comment